Altogether, MYC amplification is found in 6–17% of human HCC (Ally et al, 2017), while MYC pathway is activated in close to 30% of human HCC (Kaposi-Novak et al, 2009), making it a relevant alteration in the context of oncogenic cooperation. Here, MYC is linked to hepatocellular carcinoma.